Advanced search
Publication Cover
Expert Review of Proteomics Volume 17, 2020 - Issue 10
Submit an article Journal homepage
2,036
Views
2
CrossRef citations to date
0
Altmetric
Editorial

Off-target identification by chemical proteomics for the understanding of drug side effects

Yabing Songa West China School of Basic Medical Sciences & Forensic Medicine, Center of Reproductive Medicine, West China Second University Hospital, and State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, P.R. ChinaView further author information
,
Li Luoa West China School of Basic Medical Sciences & Forensic Medicine, Center of Reproductive Medicine, West China Second University Hospital, and State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, P.R. China;b Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry ofEducation, Chengdu, P.R. ChinaView further author information
&
Kui Wanga West China School of Basic Medical Sciences & Forensic Medicine, Center of Reproductive Medicine, West China Second University Hospital, and State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, P.R. ChinaCorrespondence[email protected]
View further author information
Pages 695-697 | Received 05 Nov 2020, Accepted 04 Jan 2021, Published online: 12 Jan 2021

References

  • International drug monitoring: the role of national centres. Report of a WHO meeting. World Health Organ Tech Rep Ser. 1972;498:1–25.
  • Zielinski DC, Filipp FV, Bordbar A, et al. Pharmacogenomic and clinical data link non-pharmacokinetic metabolic dysregulation to drug side effect pathogenesis. Nat Commun. 2015 Jun;9(6):7101. .
  • Zhu H, Tamura T, Hamachi I. Chemical proteomics for subcellular proteome analysis. Curr Opin Chem Biol. 2019 Feb;48:1–7.
  • Roberts AM, Ward CC, Nomura DK. Activity-based protein profiling for mapping and pharmacologically interrogating proteome-wide ligandable hotspots. Curr Opin Biotechnol. 2017 Feb;43:25–33.
  • Benns HJ, Wincott CJ, Tate EW, et al. Activity- and reactivity-based proteomics: recent technological advances and applications in drug discovery. Curr Opin Chem Biol. 2020 Aug;5(60):20–29.
  • Wright MH, Sieber SA. Chemical proteomics approaches for identifying the cellular targets of natural products. Nat Prod Rep. 2016 May 4;33(5):681–708.
  • Chen X, Wang Y, Ma N, et al. Target identification of natural medicine with chemical proteomics approach: probe synthesis, target fishing and protein identification. Signal Transduct Target Ther. 2020 May 21;5(1):72.
  • van Esbroeck ACM, Janssen APA, Cognetta AB 3rd, et al. Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474. Science. 2017 Jun 9;356(6342):1084–1087.
  • Wang J, Zhang C-J, Zhang J, et al. Mapping sites of aspirin-induced acetylations in live cells by quantitative acid-cleavable activity-based protein profiling (QA-ABPP). Sci Rep. 2015;5:1.
  • Wang K, Yang T, Wu Q, et al. Chemistry-based functional proteomics for drug target deconvolution. Expert Rev Proteomics. 2012 Jun;9(3):293–310. .
  • Ito T, Ando H, Suzuki T, et al. Identification of a primary target of thalidomide teratogenicity. Science. 2010 Mar 12;327(5971):1345–1350. .
  • Wang K, Zhang T, Lei Y, et al. Identification of ANXA2 (annexin A2) as a specific bleomycin target to induce pulmonary fibrosis by impeding TFEB-mediated autophagic flux. Autophagy. 2018;14(2):269–282. .
  • Burgy O, Wettstein G, Bellaye PS, et al. Deglycosylated bleomycin has the antitumor activity of bleomycin without pulmonary toxicity. Sci Transl Med. 2016 Feb 17;8(326):326ra20.
  • Lomenick B, Hao R, Jonai N, et al. Target identification using drug affinity responsive target stability (DARTS). Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21984–21989. .
  • Savitski MM, Reinhard FBM, Franken H, et al., Tracking cancer drugs in living cells by thermal profiling of the proteome. Science. 2014;346(6205):1255784. .
  • Isabelle Becher TW, Doce C, Zaal EA, et al. Thermal profiling reveals phenylalanine hydroxylase as an off-target of panobinostat. Nat Chem Biol. 2016;12:908–910.
  • Gaetani M, Sabatier P, Saei AA, et al. Proteome integral solubility alteration: a high-throughput proteomics assay for target deconvolution. J Proteome Res. 2019;18(11):4027–4037.
  • Chernobrovkin A, Marin-Vicente C, Visa N, et al. Functional identification of target by expression proteomics (FITExP) reveals protein targets and highlights mechanisms of action of small molecule drugs. Sci Rep. 2015;5(1):11176. .
  • Saei AA, Beusch CM, Chernobrovkin A, et al. ProTargetMiner as a proteome signature library of anticancer molecules for functional discovery. Nat Commun. 2019;10(1):5715.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.